Journal Reviews

Short-term effects of intravitreal bevacizumab on the cornea

1 December 2014 | | Cornea / External Eye Disease | anterior chamber depth, bevacizumab, central corneal thickness, intraocular pressure, iridocorneal angle, simulated keratometry

Bevacizumab has been extensively used to treat macula oedema and neovascularisation of the retina and it has also been useful in the management of corneal neovascular diseases. This prospective study aimed to provide more information on the effect bevacizumab may...